NHMRC has recently approved Clinical Practice Guidelines on Magnesium Sulphate Prior to Preterm Birth for Neuroprotection of the Fetus, Infant and Child that was developed by the Australian Research Centre for the Health of Women and Babies (ARCH).
NHMRC has recently approved Clinical Practice Guidelines on Magnesium Sulphate Prior to Preterm Birth for Neuroprotection of the Fetus, Infant and Child that was developed by the Australian Research Centre for the Health of Women and Babies (ARCH).
No comments:
Post a Comment
Thank you for your comment. Your comment will be moderated before publishing. Thank you.